Status:
TERMINATED
Hemodilution and Outcome in Cardiac Surgery
Lead Sponsor:
Università Vita-Salute San Raffaele
Conditions:
Kidney Failure
Intraoperative Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
An hematocrit of 21-25% is supposed to perform the best organ protection during cardiopulmonary bypass for cardiac surgery. The investigators want to establish the best timing for a transfusion (in p...
Eligibility Criteria
Inclusion
- Undergoing cardiac surgery
Exclusion
- Age \< 18 years old
- Not signing written consent
- Age \< 65 years old (subgroup 1)
- Emergency, aortic stenosis, main left coronary stenosis (subgroup 2)
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00364494
Start Date
November 1 2006
End Date
April 1 2007
Last Update
August 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia
Milan, Italy, 20132